Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04995861
Other study ID # AinShamsU Shabayek MD
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date April 20, 2021
Est. completion date September 30, 2022

Study information

Verified date July 2022
Source Ain Shams University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A comparison between The analgesic efficacy of adductor canal block alone and adductor canal with IPACK (interspace between popliteal artery and capsule of the knee) block for knee surgeries


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 50
Est. completion date September 30, 2022
Est. primary completion date September 20, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 70 Years
Eligibility Inclusion Criteria: - patients undergoing knee surgery i.e. arthroscopy, total knee replacement, ACL repair. - ASA physical status I to III - Sex (males and females) - Age 21-70 years. Exclusion Criteria: - Hypersensitivity to local anesthetics. Preexisting peripheral neuropathy. Infection near site of infections e.g. osteomyelitis, septic knee joint. Etc. Patient refusal. PAny contraindications for spinal anesthesia. ( eg: coagulopathy, use of anticoagulants

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Adductor canal block and IPACK block
Peripheral nerve blocks

Locations

Country Name City State
Egypt Ain Shams University Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of post operative pain Using visual analogue scale (VAS) (scale 0-10, where 0 = no pain and 10 = worst imaginable pain) One year
Secondary Range of movement and ambulation the range of movement (ROM) by assessing the degree of knee extension one day after the surgery, and ambulation distance assessed by the number of steps walked by the patient three days after the surgery. One year
See also
  Status Clinical Trial Phase
Completed NCT03059498 - PECS Block: Plasma Bupivacaine Level Early Phase 1
Completed NCT06028061 - Evaluation of Effectivity of Quadratus Lumborum Blocks With Adjuvant N/A
Completed NCT04036370 - Continuous Pectoral Nerve Block in Breast Cancer Surgery N/A
Not yet recruiting NCT06219005 - Ultrasound-guided Nerve Block Training Model and Evaluation Method N/A
Completed NCT03857386 - Efficacy of Pectoral Nerve Block for Breast Reduction Surgery
Completed NCT04210700 - Comparing Fascia Iliaca Compartment Block and Pericapsular Nerve Group Block for Hip Fracture Pain Control N/A
Completed NCT02067078 - Protracted Effect of Combined Nerve Blocks After Total Knee Arthroplasty Phase 4